Drug Profile
Research programme: antifungals - Arrow Therapeutics
Alternative Names: Antifungals research programme - Arrow TherapeuticsLatest Information Update: 14 Apr 2005
Price :
$50
*
At a glance
- Originator Arrow Therapeutics
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 14 Apr 2005 Discontinued - Preclinical for Mycoses in United Kingdom (unspecified route)
- 31 Mar 2004 This programme is still in active development - (BioSquare-2004)
- 29 Jan 2001 Preclinical development for Mycoses in United Kingdom (Unknown route)